ArticleBioinformatics advances2026
TPdsm: a method based on TabPFN for prediction of deleterious synonymous mutations.
Article in Bioinformatics advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Motivation: Assessing the deleteriousness of synonymous mutations is of considerable importance for understanding human health, and the development of corresponding prediction methods offers a rapid and efficient approach. However, the scarcity of training data remains a major bottleneck in building high-performance predictors for synonymous mutation deleteriousness. Herein, we present TPdsm, a novel method for predicting deleterious synonymous mutations. Results: TPdsm leverages TabPFN, a tabular foundation model specifically designed for small-sample prediction. The features are retrieved from CDsyn, a comprehensive database dedicated to deleterious synonymous mutation prediction. Our evaluation demonstrates that TPdsm delivers better predictive performance than a set of 14 current state-of-the-art predictors, as evidenced by its results across multiple independent testing datasets and real-world cases. Availability and implementation: TPdsm is available on GitHub at https://github.com/Project4bz2023/TPdsm. The pre-computed score of TPdsm can be accessed at https://doi.org/10.5281/zenodo.18265619. The result can be queried at https://bingtseng-tpdsm.share.connect.posit.cloud/.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.